Clinical Evaluation of Leech Therapy in the Treatment of Knee Osteoarthritis

Knee Osteoarthritis Clinical Trial

— Leech Therapy  

Official title:

Randomized Controlled Clinical Evaluation of Leech Therapy in the Treatment of Knee Osteoarthritis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02612974
• Other study ID #: 2009/AD/JH/058
• Status: Completed
• Phase: Phase 2
• First received: November 20, 2015
• Last updated: November 23, 2015
• Start date: January 2010
• Est. completion date: June 2012

Study information

• Verified date: November 2015
• Source: Hamdard University
• Contact: n/a
• Is FDA regulated: No
• Health authority: India: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

This study has been designed to conduct as Randomized comparative clinical study.

Description:

Two groups, group B received Qurse Mafasil tablet orally two tablets two times daily for 8 weeks while group A received Leech therapy once weekly for 8 weeks along with Qurse mafasil.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: June 2012
• Est. primary completion date: March 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years to 70 Years

Eligibility

Inclusion Criteria:

• knee osteoarthritis

Exclusion Criteria:

• pregnancy,

• lactation,

• anaemia

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Knee Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Knee

Intervention

Biological:
• Hirudinaria granulosa, qurse mafasil
compare the efficacy of both groups

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Hamdard University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	KOOS Score		end of 6 weeks	No
Primary	VAS		end of 6 weeks	No
Primary	Active Range of Motion		end of 6 weeks	No
Primary	Knee circumference		end of 6 weeks	No
Primary	15 m walking time test		end of 6 weeks	No
Secondary	KOOS subscores		end of 6 weeks	No